MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.jad.2025.120724

Медицинская библиотека · Journal of affective disorders · 2025

Longitudinal impact of CYP2D6 and CYP2C19 metabolizer status on antidepressant response: The role of Pharmacogenetic mismatch.

Serretti Alessandro, Barlati Stefano, Buson Lisa, Menesello Valentina, Magistrali Anna, Silva Rosana Carvalho, Perusi Giulia, Nibbio Gabriele, Bignotti Stefano, PANDORA study group, Tura Giovanni Battista, Vita Antonio, Ferri Raffaele, Fabbri Chiara, Gennarelli Massimo, Minelli Alessandra

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Pharmacogenetic (PGx) guidance for antidepressants focuses on cytochrome (CYP) 2D6 and 2C19, yet real-world evidence on clinically mismatched prescriptions i.e., drugs whose metabolism is not concordant with a patient's PGx phenotype, remains limited.

METHODS

In this 12-week prospective study we genotyped 244 outpatients with major depressive disorder (MDD) and classified their current antidepressant as CYP mismatch (n = 114, 46.7 %) or no mismatch (n = 130, 53.3 %). Longitudinal change in Hamilton Depression Rating Scale (HAMD) percentage improvement was analysed with a mixed-effects model. Safety was assessed with the Udvalg for Kliniske Undersøgelser (UKU) scale.

RESULTS

The primary model showed a detrimental effect of mismatch on HAM-D improvement (β = -14.65 ± 7.42 %, p = 0.048) and a non-significant trend for time × mismatch interaction (β = 1.30 ± 0.76 %/week, p = 0.088). By week 12, mean improvement was 59.3 ± 25.6 % in the no-mismatch group versus 54.9 ± 28.8 % in mismatch. Overall response (32.1 % vs 37.9 %, p = 0.46) and remission rates (43.8 % vs 50.5 %, p = 0.39) did not differ. Conversely, UKU global scores were significantly higher in mismatch both at week 8 (1.43 ± 1.23 vs 1.07 ± 1.16, p = 0.025) and week 12 (1.03 ± 1.16 vs 0.72 ± 1.09, p = 0.048).

CONCLUSIONS

While categorical response and remission rates did not differ between groups and numerically favored the mismatch group, side-effect burden was modestly higher with mismatch; continuous trajectories nevertheless showed a small but consistent disadvantage associated with mismatch.

Для цитирования: Serretti Alessandro, Barlati Stefano, Buson Lisa, Menesello Valentina, Magistrali Anna, Silva Rosana Carvalho, Perusi Giulia, Nibbio Gabriele, Bignotti Stefano, PANDORA study group, Tura Giovanni Battista, Vita Antonio, Ferri Raffaele, Fabbri Chiara, Gennarelli Massimo, Minelli Alessandra. Longitudinal impact of CYP2D6 and CYP2C19 metabolizer status on antidepressant response: The role of Pharmacogenetic mismatch.. Journal of affective disorders. 2025. DOI: 10.1016/j.jad.2025.120724.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.